Formulation considerations for dry powder inhalers.

about

Drug Delivery Approaches in Addressing Clinical Pharmacology-Related Issues: Opportunities and Challenges Generation of tailored aerosols for inhalative drug delivery employing recent vibrating-mesh nebulizer systems.

P2860

Q26798105-FAD4D5F3-FF29-4A95-8EF3-9BDE6DE85D92 Q38498038-1438B8F6-6777-4AAE-8DC8-63B48D29AF76

P2860

Formulation considerations for dry powder inhalers.

Item

http://www.wikidata.org/entity/Q38236695

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Formulation considerations for dry powder inhalers.

@en

type

Item

label

Formulation considerations for dry powder inhalers.

@en

prefLabel

Formulation considerations for dry powder inhalers.

@en

P1476

Formulation considerations for dry powder inhalers.

@en

P2093

Eike Cordts

http://www.w3.org/2001/XMLSchema#string

Hartwig Steckel

http://www.w3.org/2001/XMLSchema#string

P2860

Drug content effects on the dispersion performance of adhesive mixtures for inhalation

Protein spray-freeze drying. Effect of atomization conditions on particle size and stability.

The influence of relative humidity on particulate interactions in carrier-based dry powder inhaler formulations.

Design and in vitro performance testing of multiple air classifier technology in a new disposable inhaler concept (Twincer) for high powder doses.

The effect of carrier surface treatment on drug particle detachment from crystalline carriers in adhesive mixtures for inhalation.

Dose emission characteristics of placebo PulmoSphere® particles are unaffected by a subject's inhalation maneuver.

On the use of dry powder inhalers in situations perceived as constrained.

Overcoming dose limitations using the orbital(®) multi-breath dry powder inhaler.

Novel alternative methods for the delivery of drugs for the treatment of asthma.

Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications.

P304

675-689

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4155/TDE.14.35

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25090281

http://www.w3.org/2001/XMLSchema#string

Formulation considerations for dry powder inhalers.

about

P2860

P2860

Formulation considerations for dry powder inhalers.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698